ADC is known as precision therapy, which delivers drugs precisely to tumor cells through targeted antibodies, maximizing tumor destruction while minimizing damage to normal tissues. In the design of ADC, antibodies are responsible for “navigation,” while the payload (toxin) is the true “terminator.” This article will delve into the classification of mainstream ADC payloads, why topoisomerase I inhibitors have gained popularity, and DAR (…